P53 together with ferroptosis: a promising strategy leaving cancer cells without escape

被引:10
作者
Zhan, Jianhao [1 ,2 ]
Wang, Jisheng [1 ]
Liang, Yuqing [3 ]
Zeng, Xiaoping [3 ,4 ]
Li, Enliang [1 ]
Wang, Hongmei [3 ,4 ]
机构
[1] Nanchang Univ, Dept Gen Surg, Affiliated Hosp 2, Nanchang 330006, Jiangxi, Peoples R China
[2] Nanchang Univ, HuanKui Acad, Nanchang 330006, Jiangxi, Peoples R China
[3] Nanchang Univ, Sch Basic Med Sci, Nanchang 330006, Jiangxi, Peoples R China
[4] Jinhua Polytech, Coll Med, Jinhua 321017, Zhejiang, Peoples R China
来源
ACTA BIOCHIMICA ET BIOPHYSICA SINICA | 2024年 / 56卷 / 01期
基金
中国国家自然科学基金;
关键词
p53; ferroptosis; lipid peroxidation; ferroptosis signaling; cancer therapy; TEMPERATURE-SENSITIVE MUTANT; TUMOR-SUPPRESSOR; POLYAMINE METABOLISM; EXTRACELLULAR-MATRIX; LIPID-PEROXIDATION; WILD-TYPE; IN-VIVO; ACTIVATION; EXPRESSION; MDM2;
D O I
10.3724/abbs.2023270
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
TP53, functioning as the keeper of the genome, assumes a pivotal function in the inhibition of tumorigenesis. Recent studies have revealed that p53 regulates ferroptosis pathways within tumor cells and is closely related to tumorigenesis. Therefore, we summarize the pathways and mechanisms by which p53 regulates ferroptosis and identify a series of upstream and downstream molecules involved in this process. Furthermore, we construct a p53-ferroptosis network centered on p53. Finally, we present the progress of drugs to prevent wild-type p53 (wtp53) degeneration and restore wtp53, highlighting the deficiencies of drug development and the prospects for p53 in cancer treatment. These findings provide novel strategies and directions for future cancer therapy.
引用
收藏
页码:1 / 14
页数:14
相关论文
共 138 条
[11]   Tumor suppressor p53: Biology, signaling pathways, and therapeutic targeting [J].
Borrero, Liz J. Hernandez ;
El-Deiry, Wafik S. .
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2021, 1876 (01)
[12]   TP53 Variations in Human Cancers: New Lessons from the IARC TP53 Database and Genomics Data [J].
Bouaoun, Liacine ;
Sonkin, Dmitriy ;
Ardin, Maude ;
Hollstein, Monica ;
Byrnes, Graham ;
Zavadil, Jiri ;
Olivier, Magali .
HUMAN MUTATION, 2016, 37 (09) :865-876
[13]   Correcting temperature-sensitive protein folding defects [J].
Brown, CR ;
HongBrown, LQ ;
Welch, WJ .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 99 (06) :1432-1444
[14]   Targeting mutant p53 for efficient cancer therapy [J].
Bykov, Vladimir J. N. ;
Eriksson, Sofi E. ;
Bianchi, Julie ;
Wiman, Klas G. .
NATURE REVIEWS CANCER, 2018, 18 (02) :89-102
[15]   Mechanisms of ferroptosis [J].
Cao, Jennifer Yinuo ;
Dixon, Scott J. .
CELLULAR AND MOLECULAR LIFE SCIENCES, 2016, 73 (11-12) :2195-2209
[16]   Dual inhibition of MDMX and MDM2 as a therapeutic strategy in leukemia [J].
Carvajal, Luis A. ;
Ben Neriah, Daniela ;
Senecal, Adrien ;
Benard, Lumie ;
Thiruthuvanathan, Victor ;
Yatsenko, Tatyana ;
Narayanagari, Swathi-Rao ;
Wheat, Justin C. ;
Todorova, Tihomira I. ;
Mitchell, Kelly ;
Kenworthy, Charles ;
Guerlavais, Vincent ;
Annis, D. Allen ;
Bartholdy, Boris ;
Will, Britta ;
Anampa, Jesus D. ;
Mantzaris, Ioannis ;
Aivado, Manuel ;
Singer, Robert H. ;
Coleman, Robert A. ;
Verma, Amit ;
Steidl, Ulrich .
SCIENCE TRANSLATIONAL MEDICINE, 2018, 10 (436)
[17]   Targeting polyamine metabolism and function in cancer and other hyperproliferative diseases [J].
Casero, Robert A., Jr. ;
Marton, Laurence J. .
NATURE REVIEWS DRUG DISCOVERY, 2007, 6 (05) :373-390
[18]   Serine 392 phosphorylation modulates p53 mitochondrial translocation and transcription-independent apoptosis [J].
Castrogiovanni, Cedric ;
Waterschoot, Beranger ;
De Backer, Olivier ;
Dumont, Patrick .
CELL DEATH AND DIFFERENTIATION, 2018, 25 (01) :190-203
[19]   p53 regulates epithelial-mesenchymal transition and stem cell properties through modulating miRNAs [J].
Chang, Chun-Ju ;
Chao, Chi-Hong ;
Xia, Weiya ;
Yang, Jer-Yen ;
Xiong, Yan ;
Li, Chia-Wei ;
Yu, Wen-Hsuan ;
Rehman, Sumaiyah K. ;
Hsu, Jennifer L. ;
Lee, Heng-Huan ;
Liu, Mo ;
Chen, Chun-Te ;
Yu, Dihua ;
Hung, Mien-Chie .
NATURE CELL BIOLOGY, 2011, 13 (03) :317-U296
[20]   p53 expression controls prostate cancer sensitivity to chemotherapy and the MDM2 inhibitor Nutlin-3 [J].
Chappell, William H. ;
Lehmann, Brian D. ;
Terrian, David M. ;
Abrams, Stephen L. ;
Steelman, Linda S. ;
McCubrey, James A. .
CELL CYCLE, 2012, 11 (24) :4579-4588